Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|January 7, 1999
Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftmentF Beaujean, J H Bourhis, C Bayle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Exudative gastropathy associated with cytomegalovirus infection after allogenic bone marrow transplantation]J P Cervoni, J L Pico, M Fabre, et al.
Bone Marrow Transplantation|May 1, 1996
Protein-losing gastropathy associated with cytomegalovirus: a rare and late complication of allogeneic bone marrow transplantationC Pinho Vaz, A Ibrahim, A Avila Garavito, et al.
Hematology and Cell Therapy|January 29, 2000
Unfractionated peripheral blood stem cell autografts and CD(34+)-enriched autografts have similar long-term culture initiating capacity in multiple myelomaA G Turhan, J H Bourhis, M L Bonnet, et al.
Bone Marrow Transplantation|March 24, 2015
Changes in intensive care for allogeneic hematopoietic stem cell transplant recipientsE Lengliné, S Chevret, A-S Moreau, et al.
Blood|July 1, 1992
Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridizationW R Gerritsen, J Donohue, J Bauman, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignanciesA Ulusakarya, E Chachaty, J M Vantelon, et al.
Leukemia & Lymphoma|July 16, 2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationE Jabbour, N Peslin, P Arnaud, et al.
Leukemia|February 20, 2003
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blastsV Ribrag, F Suzan, C Ravoet, et al.
Pageof 8